NorthCrest Asset Manangement’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
MGP
AIM
NorthCrest Asset Manangement's DGX Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Quest Diagnostics (DGX) stake by 11% in Q2 2026, buying an estimated $31.6K and bringing the position to 1,656 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #687.
NorthCrest Asset Manangement first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $3M in Q4 2021. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- NorthCrest Asset Manangement held 1,656 shares of Quest Diagnostics worth $345K as of Q2 2026.
- NorthCrest Asset Manangement bought 161 Quest Diagnostics shares in Q2 2026, an estimated $31.6K.
- Quest Diagnostics made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #687 holding.
- NorthCrest Asset Manangement first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Quest Diagnostics position peaked at $3M in Q4 2021.
- 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.